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Abstract
Background: Pendred syndrome, an autosomal-recessive disorder characterized by deafness and goiter, is caused by a mutation
of SLC26A4, which codes for the anion exchanger pendrin. We investigated the relationship between pendrin expression and
deafness using mice that have (Slc26a4+/+ or Slc26a4+/-) or lack (Slc26a4-/-) a complete Slc26a4 gene. Previously, we reported that
stria vascularis of adult Slc26a4-/- mice is hyperpigmented and that marginal cells appear disorganized. Here we determine the time
course of hyperpigmentation and marginal cell disorganization, and test the hypothesis that inflammation contributes to this tissue
degeneration.
Methods: Slc26a4-/- and age-matched control (Slc26a4+/+ or Slc26a4+/-) mice were studied at four postnatal (P) developmental
stages: before and after the age that marks the onset of hearing (P10 and P15, respectively), after weaning (P28-41) and adult (P74-
170). Degeneration and hyperpigmentation stria vascularis was evaluated by confocal microscopy. Gene expression in stria
vascularis was analyzed by microarray and quantitative RT-PCR. In addition, the expression of a select group of genes was quantified
in spiral ligament, spleen and liver to evaluate whether expression changes seen in stria vascularis are specific for stria vascularis
or systemic in nature.
Results: Degeneration of stria vascularis defined as hyperpigmentation and marginal cells disorganization was not seen at P10 or
P15, but occurred after weaning and was associated with staining for CD68, a marker for macrophages. Marginal cells in Slc26a4-/-
, however, had a larger apical surface area at P10 and P15. No difference in the expression of Lyzs, C3 and Cd45 was found in stria
vascularis of P15 Slc26a4+/- and Slc26a4-/- mice. However, differences in expression were found after weaning and in adult mice. No
difference in the expression of markers for acute inflammation, including Il1a, Il6, Il12a, Nos2 and Nos3 were found at P15, after
weaning or in adults. The expression of macrophage markers including Ptprc (= Cd45), Cd68, Cd83, Lyzs, Lgals3 (= Mac2 antigen),
Msr2, Cathepsins B, S, and K (Ctsb, Ctss, Ctsk) and complement components C1r, C3 and C4 was significantly increased in stria
vascularis of adult Slc26a4-/- mice compared to Slc26a4+/+ mice. Expression of macrophage markers Cd45 and Cd84 and complement
components C1r and C3 was increased in stria vascularis but not in spiral ligament, liver or spleen of Slc26a4-/- compared to
Slc26a4+/- mice. The expression of Lyzs was increased in stria vascularis and spiral ligament but not in liver or spleen.
Conclusion: The data demonstrate that hyperpigmentation of stria vascularis and marginal cell reorganization in Slc26a4-/- mice
occur after weaning, coinciding with an invasion of macrophages. The data suggest that macrophage invasion contributes to tissue
degeneration in stria vascularis, and that macrophage invasion is restricted to stria vascularis and is not systemic in nature. The
delayed onset of degeneration of stria vascularis suggests that a window of opportunity exists to restore/preserve hearing in mice
and therefore possibly in humans suffering from Pendred syndrome.
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Pendred syndrome is an autosomal recessive disorder that
is characterized by profound sensorineural deafness,
abnormal iodide transport across the thyroid follicular
epithelium and an enlarged vestibular aqueduct [1,2]. It is
an important condition as it accounts for 1–10% of all
cases of hereditary deafness [3]. Pendred syndrome is
caused by mutations of the gene SLC26A4, which codes
for the protein pendrin [4]. Hearing loss in Pendred syn-
drome develops in most cases prelingually, which implies
that pendrin is not essential for hearing but that a defec-
tive pendrin protein causes hearing loss via a secondary
mechanism [3,5]. Most Pendred syndrome patients are
euthyroid, although the abnormal iodide transport in the
thyroid affects the incorporation of iodide into thyroglob-
ulin [6,7]. It is conceivable that the observed thyroid
hyperplasia (goiter), which generally develops around
puberty, ensures normal levels of thyroid hormone [2].
Pendrin is a Na+-independent exchanger for anions such
as Cl-, I-, HCO3 - and formate [8-10]. Pendrin is expressed
in the inner ear, thyroid, kidney, mammary gland, uterus,
testes, and placenta [6,11-17]. In the thyroid, pendrin is
expressed on the apical side of the thyrocytes and medi-
ates Cl-/I- exchange. In the kidney, pendrin is expressed on
the apical side of the non-A, non-B intercalated cells, cyto-
plasmic regions of the type B intercalated cells of cortical
collecting tubules, distal convoluted tubules and connect-
ing tubules and mediates Cl-/HCO3 - exchange [14,18].
Loss of pendrin does not effect the arterial pH but results
in a lower urinary pH [19]. In the inner ear, pendrin is
localized in the outer sulcus epithelial cells, root cells, api-
cal membranes of spiral prominence surface epithelial
cells and in apical membranes of spindle-shaped cells of
stria vascularis [11,17].
A model for Pendred syndrome, consisting of mice lack-
ing functional expression of pendrin, has recently been
developed [20]. Similar to patients suffering from Pen-
dred syndrome, Slc26a4-/- mice are deaf, have an enlarged
vestibular aqueduct and appear to be euthyroid. Mice, in
contrast to human patients, do not exhibit goiter. Adult
Slc26a4-/- mice do not generate an endocochlear potential,
which is generated by stria vascularis and is necessary for
normal hearing [15,17].
We have shown that adult Slc26a4-/- mice show signs of
degeneration of stria vascularis, including hyperpigmen-
tation and marginal disorganization [15,17]. It remains
unclear, however, whether hyperpigmentation and mar-
ginal cell disorganization occurred before or after the nor-
mal onset of hearing (P10 or P15, respectively). Further, it
remains unclear whether the disorganized surface epithe-
lial cells were all marginal cells or whether different cells
rose to the epithelial surface of stria vascularis, giving rise
to the disorganized appearance. In the present study, we
determined the time course of hyperpigmentation and
marginal disorganization. Further, we tested the hypothe-
sis that hyperpigmentation and marginal cell disorganiza-
tion is a consequence of tissue inflammation including an
invasion of inflammatory cells.
Methods
Animals
Breeding pairs of Slc26a4-/- and Slc26a4+/+ mice were
obtained from the colony of Dr Susan Wall (Emory Uni-
versity, Atlanta, GA, USA) to establish a new colony at
KSU. Mice used for this study were anaesthetized either
with 4% tribromoethanol (0.014 ml/g body weight i.p.)
or pentobarbitol (0.1 mg/g body weight, i.p.) and sacri-
ficed by decapitation or by transcardial perfusion. Tran-
scardial perfusion consisted of Cl-free solution (6 ml, 1
min) followed by Cl- free solution containing 4% parafor-
maldehyde (24 ml, 4 min). Cl- free solution contained
mM 150 mM Na-gluconate, 1.6 mM K2HPO4, 0.4 mM
KH2PO4, 4 mM Ca-gluconate2, 1 mM MgSO4 and 5 mM
glucose, pH 7.4.
Mice that either express (Slc26a4+/+ or Slc26a4+/-) or lack
(Slc26a4-/-) a functional pendrin gene were studied at four
developmental stages, before and after the age that marks
the onset of hearing at postnatal day 10 (P10) and P15,
respectively, after weaning (P30-41) and adult (P74-170).
Genotypes were determined by PCR as described previ-
ously [20]. All procedures involving animals were
approved by the Institutional Animal Care and Use Com-
mittee of Kansas State University.
Confocal microscopy of cryosections
Temporal bones from age matched Slc26a4-/- and
Slc26a4+/- mice were rendered blood free and fixed by
transcardial and perilymphatic perfusion with Cl- free
solution containing 4% paraformaldehyde. Temporal
bones were decalcified in EDTA, processed through a
sucrose gradient and infiltrated with polyethylene glycol.
Mid-modiolar cryosections (12 μm, CM3050S, Leica,
Nussloch, Germany) were blocked in PBS-TX (137 mM
NaCl, 10.1 mM Na2HPO4, 1.8 mM KH2PO4, 2.7 mM KCl,
pH 7.4 with 0.2% Triton X 100) and 5% bovine serum
albumin. Slides were incubated overnight at 4°C with
Alexa-488 conjugated rat anti-mouse CD68 antibody
(1:25, Serotec, Raleigh, NC, USA) in PBS-TX with 1–3%
BSA. After incubation, slides were washed with PBS-TX,
mounted with FluorSave (Calbiochem, La Jolla, CA,
USA), and viewed by confocal and laser scanning bright-
field microscopy (LSM 510 Meta, Carl Zeiss, Göttingen,
Germany).Page 2 of 15
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Temporal bones from age matched Slc26a4-/- and
Slc26a4+/- mice were rendered blood free by transcardial
perfusion with Cl- free solution. Stria vascularis was
obtained by microdissection and fixed for 2 hrs at 4°C in
Cl- free solution containing 4% paraformaldehyde,
washed twice in Cl- free solution and once in PBS-TX and
then blocked with 5% BSA in PBS- TX for 45 min at RT
and then washed three times in PBS-TX. Stria vascularis
was then incubated overnight at 4°C either with Alexa-
488 conjugated rat anti-mouse CD68 antibody (1:25, see
above) or goat anti-Kcnq1 primary antibody (1:200, C20,
Santa Cruz Biotechnology, Santa Cruz, CA, USA) in PBS-
TX with 1–3% BSA. Tissues incubated with goat anti-
Kcnq1 primary antibody were washed with PBS-TX and
incubated for 1 h at 25°C with chicken anti-goat Alexa
594 secondary antibody, 1:1,000 (Molecular Probes,
Eugene, OR, USA) in PBS-TX with 1–3% BSA.
After antibody incubation, stria vascularis was washed in
PBS-TX (0.2% Triton-X) and stained with phalloidin con-
jugated to Alexa 594 (1:40; Invitrogen, Carlsbad, CA,
USA), washed three times with PBS-TX, mounted with
FluorSave (Calbiochem), and viewed by confocal and
laser scanning brightfield microscopy (LSM 510 Meta,
Carl Zeiss).
RNA isolation
Temporal bones were removed and stria vascularis and
spiral ligament were obtained by microdissection. Micro-
dissection solutions were changed twice and isolated tis-
sues were washed to minimize contamination between
tissue fractions. In addition, liver and spleen were col-
lected and rapidly frozen in liquid nitrogen. Total RNA
was isolated and residual DNA contamination was
removed by DNase treatment (RNeasy micro, Qiagen,
Valencia, CA, USA). Frozen samples of liver and spleen
were pulverized and homogenized. Total RNA was iso-
lated and freed from DNA contamination (RNeasy mini,
Qiagen). Isolated RNA was either used immediately or
diluted and stored at -80°C for later analysis (RNA storage
solution, Ambion, Austin, TX, USA).
Gene array
Total RNA was isolated from stria vascularis of adult
Slc26a4+/+ and Slc26a4-/- mice (P148 ± 3 and P153 ± 1,
respectively). The minimal amount of blood present
within capillaries was deemed insignificant; no cardiac
perfusion was performed. Isolated RNA was concentrated
and frozen for shipment to the Biotechnology Support
Facility at University of Kansas Medical Center. A total of
six chips were run; each chip was used to analyze RNA
pooled from two animals. Three chips each were used to
analyze RNA expression in stria vascularis of Slc26a4+/+
and Slc26a4-/- mice. RNA was amplified by two rounds of
amplification, and cRNA was hybridized to high-density
oligonucleotide gene chips (Small sample protocol, ver-
sion II; mouse 430 2.0 gene chip, Affymetrix, Santa Clara,
CA, USA). Gene array data were analyzed using commer-
cial software (GCOS, Affymetrix; Genespring, Silicon
Genetics, Redwood City, CA, USA) as well as custom-writ-
ten macros (Excel, Microsoft, Redmond, WA, USA). Qual-
ity metrics conformed with MIAME standards (Table 1).
Present/absent calls and averaged signal intensities (aver-
age of data obtained from three chips) were used to deter-
mine expression and changes in expression levels,
respectively.
In the tabulated data summaries, 'Intensity' for Slc26a4+/+
and for Slc26a4-/- samples represents averages of data from
one or more probes. For example, the gene Slc12a2 is rep-
resented on the chip by four probes. Present calls (P) were
summarized for all three chips, e.g. 12/12 indicates that
this gene was called present by all 12 probes (4 × 3 = 12);
9/15 indicates that the gene is represented by 5 probes on
the 3 chips (5 × 3 = 15) and that the gene was called
present by 9 of the 15 probes.
Ratios of intensity values (Slc26a4-/- to Slc26a4+/+) were
calculated for each probe and averaged. Average ratios >
1.000 were reported as Fold with the Direction 'up'. Aver-
age ratios < 1.000 were inverted (1/average ratio) and
reported as Fold with the Direction 'down'. Fold values are
given in the tables only when the gene was called Present
(P) in Slc26a4+/- or Slc26a4-/- samples in at least half of the
available probes. The direction of the fold change is only
given when it exceeded 1.30. Fold changes lower than
1.30 were not considered significant.
Quantitative RT-PCR
Age and sex matched Slc26a4-/- and Slc26a4+/- mice were
rendered blood free by transcardiac perfusion with Cl- free
solution. Total RNA was isolated from microdissected
stria vascularis and spiral ligaments, as well as from liver
and spleen. In each 96-well plate, the expression of seven
different genes as well as 18S rRNA was analyzed. Total
Table 1: Quality metrics of gene arrays. Gene array data were deposited at GEO (GSE4749). The required MIAME quality metrics are 
given as average ± SD.
Chips Scale Factor Average call (All) Present calls (%) Background intensity Noise Raw Q
6 3.05 ± 1.07 682.9 ± 23.6 42.2 ± 3.1 100.3 ± 18.9 5.4 ± 1.1 3.1 ± 0.5Page 3 of 15
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spleen and liver of one Slc26a4-/- and one matched
Slc26a4+/- mouse was analyzed in duplicate reactions in
parallel to allow paired comparisons (paired t-test). qRT-
PCR was performed in the presence of 0.5× SYBR green I
on total RNA isolated from individual animals using gene
specific primers (One step RT-PCR kit, Qiagen; iCycler,
BioRad, Hercules, CA, USA; SYBR green I, Molecular
Probes; Table 2). RT was performed for 30 min at 50°C
and 15 min at 95°C. PCR consisted of 40 cycles of 1 min
at 60°C, 1 min at 72°C, 20 s hot measurement, and 1 min
at 94°C. Specificity of primers was verified by sequencing.
The generation of a single product of the appropriate size
was verified by agarose gel electrophoresis.
Template molecules were quantified according to T =
10^log (PCt)/(Eavg^Ct), where PCt is product molecules at
Ct, Eavg is the average efficiency and Ct is cycle at which the
fluorescence of the product molecules reached a set
threshold. Efficiencies for individual reactions was
obtained from the slope of the log-linear phase of the
growth curve using an Excel-based program (LinRegPCR)
[21].
The number of product molecules at Ct (PCt) was calcu-
lated by amplifying known numbers of 18S rRNA (T18S)
molecules according to PCt = T18S × E18S^Ct, where E18S is
the average efficiency of all the 18S rRNA reactions. The
mass of 18S rRNA in 1 μg of total RNA was estimated to
calculate the number of 18S rRNA molecules in a given
amount of RNA sample. Calculations were based on three
assumptions: firstly, total RNA consists to 100% of 18S
and 28S rRNA. Secondly, 18S and 28S rRNA occur in a 1:1
ratio. Thirdly, murine 18S and 28S rRNA contains 1869
and 4712 nucleotides [Genbank: X00686] and [Genbank:
X00525], respectively. The mass of 18S rRNA per 1 μg of
total RNA was estimated to be 0.284 μg, equivalent to 4.7
× 10-13 mol or 2.8 × 1011 molecules of 18S rRNA (molec-
ular weight of 18S rRNA estimated to be 598,080).
Western blotting
Temporal bones from age matched Slc26a4-/- and
Slc26a4+/- mice were rendered blood free by transcardial
perfusion with Cl- free solution. Stria vascularis and spiral
ligament were isolated by microdissection. Proteins in
stria vascularis and spiral ligament from one animal were
isolated by heating (10 min, 95°C) in 20 μl of a diluent
(Compound B, NanoOrange, Invitrogen). After cooling
(20 min, RT), the isolated protein was quantified
(NanoOrange, Invitrogen) and either used immediately
in Western blots or stored at -80°C.
Proteins (15 μg per well) were denatured in the presence
of Laemmli sample buffer (62.5 mM Tris-HCl, pH 6.8,
25% glycerol, 2% SDS, 0.01% bromophenol blue, 5% 2-
mercaptoethanol) at 80°C for 5 min and resolved by elec-
trophoresis (150 V for 45 min) in 4–15% polyacrymalide
Tris-HCl gradient gels (10 well mini-gel, BioRad laborato-
Table 2: Sequences of gene specific primers
Gene Primer sequence Product length (bp)
18S gag gtt cga aga cga tca ga (sense)
tcg ctc cac caa cta aga ac (antisense) 317
C1r aac aag atg ctg ctg acc (sense)
tat tca agg ctg gag aca tag (antisense) 302
C3 atc cga tac tac acc tacc (sense)
cct ggt ttc ctt caa tcc (antisense) 307
Ptprc (Cd45) tgt tga cag agt tag tga atg g (sense)
gtg gac gag gat gga tgc (antisense) 323
Lyzs cct gct ttc tgt cac tgc tc (sense)
ggt gta atg atg gca aaa cc (antisense) 235
Il1a aca cta tct cag cac cac ttg g (sense)
gca ccc gac ttt gtt ctt tgg (antisense) 311
Il6 ctg caa gag act tcc atc c (sense)
tat atc cag ttt ggt agc atc c (antisense) 300
Il12a tca atc acg cta cct cct c (sense)
ctg ttg tgg aag aag tct ctc (antisense) 302
Nos2 gtt tga cca gag gac cca ga (sense)
acc tga tgt tgc cat tgt tg (antisense) 354
Nos3 cct aca gag cag caa atc ca (sense)
gcc ttt ctc cag ttg ttc ca (antisense) 202
Otos atg cag ccc tgt ctg ctg tgg tgg (sense)
gtc ctc ctg gta ggg aac atg gaa (antisense) 267
Tyr gcc tgt gcc tcc tct aag (sense)
ttc taa tca aga ctc gct tct c (antisense) 295Page 4 of 15
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were used to estimate molecular weights (Precision Mark-
ers, BioRad). Proteins were transferred in transblot buffer
(25 mM Tris, 192 mM glycine, 20% v/v methanol, pH
8.3). (25 V, 1 h; XCell II blot module, Invitrogen) onto a
nitrocellulose membrane (0.2 μm, BioRad).
Nitrocellulose membranes were first evaluated for lys-
ozyme expression, then stripped (Restore Western Blot
Stripping Buffer, Pierce, Rockford, IL, USA) and evaluated
for actin expression. Membranes were blocked in TBS-
Tween (20 mM Tris-Cl, pH 7.6 with 0.1% Tween) contain-
ing 5% non-fat dry milk powder (BioRad) and incubated
(1 hr RT) with rabbit anti-human lysozyme primary anti-
body (1:500; Dakocytomation, Carpinteria, CA) or rabbit
anti-Actin primary antibody (1:1,000; Sigma) in TBS-
Tween containing 5% non-fat dry milk. Membranes were
washed three times with TBS-Tween and then incubated
with horseradish peroxidase conjugated donkey anti-rab-
bit antibody (1:25,000, Amersham Biosciences) in TBS-
Tween containing 5% non-fat dry milk. The membranes
were washed again three times with TBS-Tween and then
treated with chemiluminescent detection agents (Super-
Signal West Femto Maximum Sensitivity Substrate;
Pierce), exposed to film (CL-XPosure Film, Pierce), which
was developed immediately (XOmat 2000A, Kodak,
Rochester, NY, USA).
Statistics
Numeric data are presented at average ± sem, unless spec-
ified otherwise. The number (n) of animals, blots or cells
is given. Differences were determined by paired t-tests.
Significance was assumed at p < 0.05.
Results and Discussion
Cellular reorganization of stria vascularis
Previously, we reported that stria vascularis of adult
Slc26a4-/- mice is hyperpigmented and that marginal cells
appear disorganized [15,17]. Stria vascularis was obtained
from age matched Slc26a4+/- and Slc26a4-/- mice and
hyperpigmentation was evaluated by laser-scanning light
microscopy. Hyperpigmentation was absent at P10 and
P15 but observed after weaning (P33-41) and in adult
(P84-96) Slc26a4-/- mice (Fig. 1).
Marginal cells can be identified by there expression of the
K+ channel Kcnq1 in their apical membrane [17]. To gain
information on the identity of surface epithelial cells,
expression of Kcnq1 was visualized by immunocytochem-
istry and F-actin, a marker for tight junctions, was visual-
ized by phalloidin staining. Marginal cells at all ages of
Slc26a4+/- mice and at P10 and P15 of Slc26a4-/- mice
expressed the K+ channel Kcnq1 evenly. Little variation
was observed in cell surface areas at all ages of Slc26a4+/-
mice and at P10 and P15 of Slc26a4-/- mice, and variations
appeared normally distributed (Figs 2 and 3). The average
cell surface area of marginal cells in Slc26a4+/- mice was
104 ± 2 μm2 (n = 120). No significant differences were
detected in Slc26a4+/- mice of different ages. In contrast,
the average cell surface areas of marginal cells in P10 and
P15 Slc26a4-/- mice were significantly larger, 236 ± 12 μm2
(n = 30) and 232 ± 12 μm2 (n = 30), respectively. This
Hyperpigmentation in stria vascularisFigure 1
Hyperpigmentation in stria vascularis. The time course of hyperpigmention during development was determined by laser 
scanning brightfield microscopy of stria vascularis whole-mounts. Top: images from Slc26a4+/- mice of various ages (P, postnatal 
day). Bottom: images from Slc26a4-/- mice. Note that hyperpigmentation (arrows) was observed in Slc26a4-/- mice at P33 and 
P84 but not at P10 or P15. No hyperpigmentation was observed in Slc26a4+/- mice. The scale bar shown in the bottom right 
image represents 10 μm and pertains to all images in this figure.Page 5 of 15
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consistent with the understanding that Slc26a4+/- and
Slc26a4-/- mice do not differ in the total number of mar-
ginal cells, and that cell surface areas are enlarged to cover
the larger area that results from the enlarged cochlear
diameter found in Slc26a4-/- mice.
After weaning, marginal cells of Slc26a4-/- mice began to
reorganize, leading to a multimodal distribution of cell
surface areas (Figs 2 and 3). Most interestingly, marginal
cells that reduced their surface areas from ~ 240 to ~ 100
μm2 retained dense expression of Kcnq1, whereas mar-
ginal cells that increased their surface area gradually lost
Kcnq1 expression. The degree of Kcnq1 staining in stria
vascularis of P37 Slc26a4-/- mice correlated inversely with
the size of the cell surface area. Stria vascularis of adult
Slc26a4-/- mice consisted of a mosaic of Kcnq1-expressing
and degenerated marginal cells. Kcnq1-expressing mar-
ginal cells are likely to remain functional, given that Kcnq1
is essential for K+ secretion and the endolymphatic K+ con-
centration was found to be normal (~ 140 mM) in adult
Slc26a4-/- mice [17,22,23].
Expression analysis by gene array
Gene expression in stria vascularis was analyzed by gene
array to gain data on the cause of marginal cells reorgani-
zation. The quality of the gene array was determined by
quality metrics (Table 1), and the quality of the expression
analysis was determined by an evaluation of genes that are
known to be expressed in stria vascularis (Table 3) and by
an evaluation of genes that are known to be expressed in
neighboring tissues that could have served as sources of
contamination (Table 4). As expected, genes known to be
expressed in marginal, intermediate basal and spindle
cells were present in Slc26a4+/+ and Slc26a4-/- mice (Table
3). Interestingly, genes known to be expressed in marginal
cells were downregulated in Slc26a4-/- mice (Table 3A). In
contrast, no change in expression was observed for genes
known to be expressed in intermediate and/or basal cells
(Table 3B). These data are consistent with a partial degen-
eration of marginal cells.
Genes known to be expressed in neighboring tissues were
not found in stria vascularis, with the exception of otospi-
ralin (Otos). Otos in known to be expressed in spiral liga-
ment [24], which is the tissue adjacent to stria vascularis
(Table 4). Taken together, these data demonstrate that
gene array analysis provided reliable data of expression in
stria vascularis.
Macrophage invasion of stria vascularis
Gene array analysis revealed that stria vascularis of adult
Slc26a4-/- mice expresses markers specific and/or consist-
ent with the presence of macrophages (Table 5). Expres-
Loss of Kcnq1 expression in marginal cellsFigure 2
Loss of Kcnq1 expression in marginal cells. The time course of marginal cell reorganization during development was 
determined by confocal immunohistochemistry of Kcnq1 (red) and phalloidin-staining of α-actin (green) of stria vascularis in 
whole-mounts. Top, images from Slc26a4+/- mice of various ages. Bottom, images from Slc26a4-/- mice. Note that marginal cells 
of Slc26a4+/- mice expressed Kcnq1 homogeneously in their apical membrane and that apical membrane surface areas displayed 
little variation in size. Marginal cells of Slc26a4-/- mice at P10 and P15 expressed Kcnq1 homogeneously, too, and apical mem-
brane surface areas showed little variation in size. However, surface areas were larger compared to Slc26a4+/- mice. At P37, 
expression of Kcnq1 in Slc26a4-/- mice was reduced in some marginal cells and maintained in others. Loss of Kcnq1 expression 
correlated with an enlargement of the apical membrane surface area and maintenance of Kcnq1 expression correlated with a 
reduction in the apical membrane surface area. This segregation of marginal cells was more drastic at P96. The scale bar shown 
in the bottom right image represents 10 μm and pertains to all images in this figure.Page 6 of 15
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Reorganization of marginal cellsFigure 3
Reorganization of marginal cells. Apical surface areas of marginal cells were measured using images of whole-mounts of 
stria vascularis as shown in Fig. 2. Frequency histograms (bin size 25 μm2) of surface area measurements were constructed. 
The number (n) of cells contributing to each histogram is given. Note that surface areas in Slc26a4+/- mice of all ages were nor-
mally distributed and narrowly centered at ~ 100 μm2. The distribution of surface areas in Slc26a4-/- mice progressed during 
development from a distribution centered at ~ 240 μm2 to a wide multimodal distribution with peaks centered at ~ 100 and ~ 
240 μm2.
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Table 4: Genes that were not expected to be expressed in stria vascularis. 
Slc26a4+/+ Slc26a4-/-
No. Gene Description Intensity P Intensity P Fold Direction
1 Pres Prestin 53 0/3 8 0/3
2 Kcnq4 K+ channel 160 0/6 160 0/6
3 Atp2b2 PMCA2 35 0/9 116 3/9
4 Calb1 Calbinin 28K 53 0/12 36 0/12
5 Calb2 Calretinin 28 0/3 27 0/3
6 Ache Acetylcholinesterase 57 0/3 5 0/3
7 Slc1a3 Glutamate transporter GLAST 122 3/18 154 8/18
8 Gria1 Glutamate receptor, ionotropic 57 0/9 55 0/9
9 Atp6v1b1 H+ ATPase 58 0/3 26 0/3
10 Tecta Tectorin, alpha 62 0/3 52 0/3
11 Tectb Tectorin, beta 90 0/3 01 0/3
12 Otog Otogelin 230 0/3 63 0/3
13 Otof Otoferlin 231 0/3 214 0/3
14 Otop1 Otopetrin 1 54 0/3 62 1/3
15 Otop2 Otopetrin 2 247 0/3 203 0/3
16 Otop3 Otopetrin 3 60 0/3 47 0/3
17 Otos Otospiralin 636 3/3 2,368 3/3 3.73 up
18 Slc4a7 Na+/HCO3 - cotransporter 398 3/3 444 3/3 1.11
19 Kcnj16 K+ channel 280 2/6 239 1/6
Genes that are expected to be expressed in the organ of Corti, the modiolus or the vestibular labyrinth but not in stria vascularis
(1–16), and genes that are expected to be expressed in spiral ligament but not in stria vascularis (17–19) are listed. For parameters 'P', 'Fold' and 
'Direction', see the Gene array section in Methods. Fold changes are given when a gene was called Present (P) in Slc26a4+/- or Slc26a4-/- samples in at 
least half of the available probes. The direction of the fold change is only given when it exceeded 1.30. Fold changes lower than 1.30 were not 
considered significant.
Table 3: Genes that were expected to be expressed in stria vascularis. 
Slc26a4+/+ Slc26a4-/-
No. Gene Description Intensity P Intensity P Fold Direction
1 Slc12a1 Na+/2Cl-/K+ cotransporter 14,664 12/12 10,656 12/12 1.33 down
2 Atp1a1 Na+/K+ ATPase, alpha 7,276 9/15 5,440 9/15 2.06 down
3 Atp1b1 Na+/K+ ATPase, beta1 10,593 12/18 8,587 12/18 1.20
4 Atp1b2 Na+/K+ ATPase, beta2 8,057 6/6 5,984 6/6 1.41 down
5 Kcnq1 K+ channel, alpha 858 15/24 542 11/24 2.48 down
6 Kcne1 K+ channel, beta 9,042 6/6 3,490 6/6 2.60 down
7 Kcnma1 K+ channel, BK 270 10/18 159 9/18 1.72 down
8 Kcnk1 K+ channel 2,667 6/6 1,670 6/6 1.92 down
9 Slc26a4 Pendrin 1,136 3/3 619 3/3 1.84 down
10 Kcnj10 K+ channel 17,169 3/3 17,005 3/3 1.01
11 Car2 Carbonic anhydrase 9,139 3/3 9,167 3/3 1.00
12 Gjb2 Connexin 26 12,785 3/3 12,629 3/3 1.01
13 Gjb6 Connexin 30 15,257 3/3 13,060 3/3 1.17
14 Sod1 Superoxide dismutase 4,149 14/15 3,538 14/15 1.21
15 Cat Catalase 3,520 6/6 4,686 6/6 1.12
16 Gpx1 Glutathione peroxidase 2,633 3/3 4,320 3/3 1.64 up
17 Gpx3 Glutathione peroxidase 12,526 3/3 9,898 3/3 1.27
18 Gpx4 Glutathione peroxidase 11,224 6/6 10,421 6/6 1.06
19 Tyr Tyrosinase 3,520 6/6 4,686 6/6 1.16
Genes that are expected to be expressed in marginal and spindle cells of stria vascularis (1–9) and genes that are expected to be expressed in 
intermediate and basal cells of stria vascularis (10–19) are listed. For parameters 'P', 'Fold' and 'Direction', see the Gene array section in Methods. Fold 
changes are given when a gene was called Present (P) in Slc26a4+/- or Slc26a4-/- samples in at least half of the available probes. The direction of the fold 
change is only given when it exceeded 1.30. Fold changes lower than 1.30 were not considered significant.
BMC Medicine 2006, 4:37 http://www.biomedcentral.com/1741-7015/4/37sion of Mac2 antigen, Itgax, Cd45, Cd83 and Cd68 is
limited to leucocytes and hematopoietic cells including
macrophages and dendritic cells [25]. Expression of major
histocompatibility complex II (MHCII) proteins is limited
to antigen-presenting cells including macrophages [25].
The expression of Lysz, a lysosomal enzyme, has been
shown to be a marker for monocytes and macrophages
[26]. Further, the increased expression of major histocom-
patibility complex I, of complement components and of
cathepsins is consistent with the presence of macrophages
although the expression of the gene is not limited to mac-
rophages [27].
Taken together, the data presented in Table 5 suggest that
stria vascularis of adult Slc26a4-/- mice is invaded by mac-
rophages. Markers for T-cells, NK-cells, B-cells, neu-
trophils and for acute inflammation were absent in stria
vascularis of Slc26a4+/+ and Slc26a4-/- mice (Tables 6 and
7). The absence of markers of acute inflammation was ver-
ified by qRT-PCR of total RNA isolated from stria vascula-
ris and spiral ligament of age and sex matched Slc26a4-/-
and Slc26a4+/- mice. No change in expression was found
for Il1a, Il6, Il12a, Nos2 and Nos3 at P15 or at P34 (each n
= 4–5; data not shown). Thus, no evidence for acute inflam-
mation was obtained. It is conceivable, however, that
short periods of acute inflammation escaped detection.
Alternatively, it is conceivable that macrophage invasion
was not preceded by neutrophil invasion and that macro-
phage recruitment occurred neutrophil-independently
[28]. The source of chemoattractants for monocytes
(MCPs) in neutrophil-independent recruitment are
endogenously harbored tissue macrophages and mes-
othelial cells [28]. Such a mechanism could be present in
stria vascularis of Slc26a4-/-mice as the cochlea endog-
enously harbors macrophages in the fibrocytes of the lat-
eral wall [29]. The mechanism of recruitment into stria
vascularis, however, remains unclear.
Table 5: Markers for macrophages/dendritic cells. 
Slc26a4+/+ Slc26a4-/-
No. Gene Description Intensity P Intensity P Fold Direction
1 Ptprc Cd45 antigen 226 3/3 946 3/3 4.19 up
2 Cd83 Cd83 antigen 126 0/3 524 3/3 4.16 up
3 Cd68 Cd68 antigen 170 3/3 1,344 3/3 7.90 up
4 Cd14 Cd14 antigen 412 1/3 619 3/3 1.50 up
5 H2-Aa MHC class II 264 5/12 1,019 9/12 4.00 up
6 H2-Ab MHC class II 126 0/9 279 3/9 1.86 up
7 H2-Eb1 MHC class II 429 0/3 1,010 3/3 2.35 up
8 Lgals3 Mac2 antigen 91 2/6 1,866 5/6 13.49 up
9 Itgax Integrin alpha X 125 0/3 375 3/3 3.00 up
10 Emr1 Mucin receptor 750 3/3 1,547 3/3 2.06 up
11 Lyzs Lysozyme 551 6/9 8257 9/9 11.78 up
12 H2-K1 MHC class I (D-region) 1,607 13/18 4,062 15/18 2.06 up
13 H2-K1 MHC class I (K-region) 1,828 6/12 2,883 6/12 1.54 up
14 H2-K1 MHC class I (Q-region) 549 1/3 890 3/3 1.62 up
15 C1r Complement 37 2/6 266 6/6 13.87 up
16 C1s Complement 71 0/3 200 1/3
17 C1qa Complement 355 1/3 2,905 3/3 8.19 up
18 C1qb Complement 552 5/6 2,001 6/6 4.43 up
19 C2 Complement 3,207 9/9 4,794 6/6 1.62 up
20 C3 Complement 11 0/3 231 2/3 20.68 up
21 C4 Complement 1,556 3/3 4,788 3/3 3.08 up
22 C3ar1 Complement receptor 177 3/9 482 6/9 2.93 up
23 Ctss Cathepsin S 2,304 3/3 7,394 3/3 3.21 up
24 Ctsk Cathepsin K 170 1/3 377 3/3 2.21 up
25 Ctsb Cathepsin B 4,172 12/15 6,576 12/15 1.90 up
26 Msr2 Macrophage scavenger receptor 169 3/3 1140 3/3 6.75 up
27 Mpeg1 Macrophage expressed gene 582 0/3 5,527 3/3 9.49 up
28 Cst3 Cystatin C 5,562 3/3 8,652 3/3 1.56 up
29 Fcgr1 IgG receptor, high affinity 98 0/6 163 5/6 1.70 up
30 Fcgr2b IgG receptor, low affinity 112 2/15 377 7/15 3.94 up
Genes that can serve as markers macrophages/dendritic cells (1–10) and genes that are consistent with the presence of macrophages/dendritic cells 
(11–27) are listed. For parameters 'P', 'Fold' and 'Direction', see the Gene array section in Methods. Fold changes are given when a gene was called 
Present (P) in Slc26a4+/- or Slc26a4-/- samples in at least half of the available probes. The direction of the fold change is only given when it exceeded 
1.30. Fold changes lower than 1.30 were not considered significant.Page 9 of 15
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Slc26a4+/+ Slc26a4-/-
No. Gene Description Intensity P Intensity P Fold Direction
1 Tcra T-cell receptor, alpha 214 0/9 190 0/9
2 Tcrb-V13 T-cell receptor, beta V13 136 4/36 109 4/36
3 Tcrb-J T-cell receptor, beta V13 71 2/15 50 1/15
4 Tcrg T-cell receptor, gamma V4 54 0/15 43 0/15
5 Cd3d Cd3 antigen 10 0/3 8 0/3
6 Cd3e Cd3 antigen 139 0/6 74 0/6
7 Cd3g Cd3 antigen 43 0/3 28 0/3
8 Cd3z Cd3 antigen 182 4/24 139 3/24
9 Cd4 Cd4 antigen 20 0/6 149 0/6
10 Cd8a Cd8 antigen 144 4/15 143 4/15
11 Cd8b Cd8 antigen 1,313 3/6 1,343 3/6
12 Ncam1 Cd56 562 8/21 654 12/21 1.16
13 Fcgr3 IgG receptor, low aff, Cd16 162 2/3 401 3/3 2.48 up
14 Sdc1 Syndecan 1 (Cd138) 77 3/12 72 3/12
15 Cd19 Cd19 antigen 15 0/3 13 0/3
16 Mpo Myeloperoxidase 159 0/3 73 0/3
17 Defb1 Beta-defensin 1 66 1/6 72 2/6
18 Defb2 Beta-defensin 2 23 0/3 14 0/3
19 Defb3 Beta-defensin 3 31 0/3 70 0/3
20 Defb4 Beta-defensin 4 85 0/3 63 0/3
21 Camp Cathelicidin 11 0/3 10 0/3
Genes that can serve as markers for T-cells (1–11), NK-cells (12–13), B-cells (14–15) and neutrophils (16–21) are listed. For parameters 'P', 'Fold' and 
'Direction', see the Gene array section in Methods. Fold changes are given when a gene was called Present (P) in Slc26a4+/- or Slc26a4-/- samples in at 
least half of the available probes. The direction of the fold change is only given when it exceeded 1.30. Fold changes lower than 1.30 were not 
considered significant.
Table 7: Genes that serve as markers for acute inflammation. 
Slc26a4+/+ Slc26a4-/-
No. Gene Description Intensity P Intensity P Fold Direction
1 Il1a Interleukin 1a 29 0/3 44 0/3
2 Il1b Interleukin 1b 173 0/3 156 0/3
3 Il6 Interleukin 6 14 0/3 31 0/3
4 Il12a Interleukin 12a 126 0/3 96 0/3
5 Il12b Interleukin 12b 70 1/6 73 1/6
6 Il10 Interleukin 10 116 3/3 87 3/3
7 Ifng Interferon, gamma 71 1/3 24 0/3
8 Tnf Tumor necrosis factor, alpha 54 0/3 50 0/3
9 Nos2 Nitric oxide synthase, inducible 19 0/3 27 0/3
Genes that can serve as markers for acute inflammation (1–9) are listed. For parameters 'P', 'Fold' and 'Direction', see the Gene array section in 
Methods. Fold changes are given when a gene was called Present (P) in Slc26a4+/- or Slc26a4-/- stria vascularis in at least half of the available probes. The 
direction of the fold change is only given when it exceeded 1.30. Fold changes lower than 1.30 were not considered significant.
Macrophage invasion is restricted to stria vascularis
The observation that stria vascularis of adult mice is
invaded by macrophages raises the question whether mac-
rophage invasion is systemic and hence found in other
organs, such as spleen and liver, or whether macrophage
invasion is restricted to stria vascularis and hence not seen
in the adjacent tissue, spiral ligament. This is an important
issue, as the inner ear is immunologically responsive to
systemic infections [30].
Total RNA was isolated from stria vascularis, spiral liga-
ment, liver and spleen from age and sex matched Slc26a4-
/- and Slc26a4+/- mice. The expression of a select group of
transcripts was evaluated by qRT-PCR. Possible contami-
nation between stria vascularis and the adjacent spiral lig-
ament was evaluated by quantifying the expression of
Otos and tyrosinase (Tyr) under the assumption that Tyr is
expressed in stria vascularis and not in spiral ligament,
and Otos in spiral ligament and not in stria vascularis. ThePage 10 of 15
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Tissue specificity of macrophage invasionF g re 4
Tissue specificity of macrophage invasion. Transcripts of markers specific for or consistent with the presence of macro-
phages in stria vascularis, spiral ligament, spleen and liver of Slc26a4+/- and Slc26a4-/- mice at P34 and/or P86 were quantified by 
qRT-PCR. Significant changes between Slc26a4+/- and Slc26a4-/- mice are marked with an asterisk (*). Numbers between bars 
represent the number of animal pairs analyzed. Note that significant increases were mainly seen in stria vascularis, to a lesser 
degree in spiral ligament, but not in spleen or liver. These data suggest that macrophage invasion is specific to stria vascularis.
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Time course of macrophage invasionF gure 5
Time course of macrophage invasion. Transcripts of markers specific for or consistent with the presence of macrophages 
in stria vascularis and spiral ligament of Slc26a4+/- and Slc26a4-/- mice at different ages were quantified by qRT-PCR to deter-
mine the time course of macrophage invasion during development. Significant changes between Slc26a4+/- and Slc26a4-/- mice 
are marked with an asterisk (*). Numbers between symbols represent the number of age-matched animal pairs analyzed. Note 
that significant differences were not seen before P34, suggesting that macrophage invasion occurred after weaning (P22).
BMC Medicine 2006, 4:37 http://www.biomedcentral.com/1741-7015/4/37detected expression level of Tyr in stria vascularis of
Slc26a4+/- and Slc26a4-/- mice was 120 ± 33 and 50 ± 13
times higher than in spiral ligament, respectively (n = 6)
and the detected expression of Otos in spiral ligament of
Slc26a4+/- and Slc26a4-/- mice was 108 ± 32 and 50 ± 28
times higher than in stria vascularis, respectively (n = 3).
These data illustrate a small contamination between stria
vascularis and spiral ligament. Contamination was larger
in Slc26a4-/- mice (2%) than in Slc26a4+/- mice (1%), con-
sistent with the observation during microdissection that
stria vascularis from Slc26a4-/- is more fragile.
Expression of complement components and macrophage
markers including C1r, C3, Ptprc (= Cd45), Cd83 and Lyzs
was increased in stria vascularis of Slc26a4-/- mice com-
pared to Slc26a4+/- mice (Fig. 4). Expression of these genes
was not upregulated in spiral ligament with the exception
of Lyzs and Cd45. Further, the expression of these genes
was not upregulated in liver or spleen (Fig. 4). Taken
together, these data suggest that macrophage invasion in
Slc26a4-/- mice is restricted to stria vascularis.
Time course of macrophage invasion
The finding that macrophage invasion was restricted to
stria vascularis raises the question of when in develop-
ment macrophage invasion occurs. Total RNA was iso-
lated from stria vascularis and spiral ligament from sex
and age matched Slc26a4-/- and Slc26a4+/- mice and a select
group of transcripts was quantified by qRT-PCR. At P15,
no difference in the expression of Lyzs, C3 and Cd45 was
found in stria vascularis or in spiral ligament between
Slc26a4-/- and Slc26a4+/- mice (Fig. 5). After weaning, and
persistent into adulthood, however, the expression of
Lyzs, C3 and Cd45 was higher in stria vascularis of Slc26a4-
/- mice compared to Slc26a4+/- mice. A similar trend was
observed with spiral ligament.
The expression of Lyzs was determined based not only on
the transcript level but also on the protein level, which
may be less prone to contamination between neighboring
tissues. Western blotting revealed that Lyzs protein is
upregulated in stria vascularis but not in spiral ligament of
post-weaning Slc26a4-/- mice (Fig. 6).
Macrophage invasion was not only determined by gene
expression analysis but also by immunohistochemistry,
using CD68 as a marker. The specificity of the anti-CD68
antibody was verified by using bone marrow cells as a pos-
itive control and heavily pigmented cells of the vestibular
labyrinth as a negative control (Fig. 7). Staining for CD68
was clearly associated with hyperpigmentation in stria
vascularis in post-weaning and adult Slc26a4-/- mice (Fig.
7).
Controls for immunohistochemistryFigu e 7
Controls for immunohistochemistry. Controls for 
CD68 immunohistochemistry were obtained from cryosec-
tions of the cochlea. Top: bone marrow cells congregated in 
cavities of the bony cochlear wall served as a positive con-
trol. Bottom: heavily pigmented cells in the connective tissue 
underneath vestibular dark cells (VDC) served as a negative 
control. Left: confocal immunohistochemistry of CD68. Right: 
corresponding bright field images. Scale bars represent 10 
μm.
Lysozyme protein expressionFigure 6
Lysozyme protein expression. Protein expression of lys-
ozyme (Lyzs) in stria vascularis and spiral ligament of post-
weaning Slc26a4+/- and Slc26a4-/- mice was determined by 
Western blotting. Actin expression served as a normalization 
control. Significant changes between Slc26a4+/- and Slc26a4-/- 
mice are marked with an asterisk (*). The number of animal 
pairs (n) is given. Note that protein expression of Lyzs was 
significantly increased in stria vascularis, but not in spiral liga-
ment.Page 13 of 15
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The data demonstrate that hyperpigmentation of stria vas-
cularis and marginal cell reorganization in Slc26a4-/- mice
occur after weaning, coinciding with an invasion of mac-
rophages. The data suggest that macrophage invasion con-
tributes to tissue degeneration in stria vascularis, and that
macrophage invasion is restricted to stria vascularis and is
not systemic in nature. The delayed onset of degeneration
of stria vascularis suggests that a window of opportunity
exists to restore/preserve hearing in mice and humans suf-
fering from Pendred syndrome.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
SVJ and AO drafted the text and PW finalized the manu-
script. SVJ carried out confocal immunocytochemistry
and morphometry. SVJ and PW isolated tissue fractions by
microdissection. AO designed primers, isolated RNA and
performed quantitative RT-PCR. RS prepared gene array
data for submission under MIAME standards. RJM carried
Macrophage invasion in stria vascularisFigure 8
Macrophage invasion in stria vascularis. Macrophages were visualized by CD68 immunohistochemistry in whole mounts 
of stria vascularis and cryosections of the cochlear lateral wall. Top row: (a-d), CD68 staining in whole mounts of stria vascula-
ris from P33 Slc26a4+/- and Slc26a4-/- mice. Immunostaining of CD68 (a and d) and corresponding bright field images (b and c) 
are shown. Second and third row: (e-p), CD68 staining in cryosections of the cochlear lateral wall from P33 and P80 Slc26a4+/- 
and Slc26a4-/- mice. Immunostaining of CD68 (e, h, k, and n), corresponding bright field images (f, i, l, and o) and merged images 
(g, j, m, and p) are shown. Note that CD68 expression is restricted to hyperpigmented areas of stria vascularis in Slc26a4-/- mice 
and that no expression of CD68 was observed in Slc26a4+/- mice. Scale bars represent 10 μm.Page 14 of 15
(page number not for citation purposes)
BMC Medicine 2006, 4:37 http://www.biomedcentral.com/1741-7015/4/37out confocal immunocytochemistry and Western blot-
ting, SF advised on immunology. PW mined gene array
data. SMW, LAE and EDG provided mice prior to the
establishment of a colony at KSU. PW conceived the
study. All authors have read and approved the final man-
uscript.
Acknowledgements
The authors would like to thank Mr. Clark Bloomer, Biotechnology Sup-
port Facility at the University of Kansas Medical Center, for expert prepa-
ration of targets and hybridization to gene arrays. Laboratory assistance 
from Nithya Raveendran, Anantha Gollapudi and Theresa Wangemann is 
gratefully acknowledged. Excel macros in support of gene array analysis 
were conceived by PW and written by Nithya Raveendran. The creation of 
the mice was supported in part by the Intramural Program of the National 
Human Genome Research Institute, National Institutes of Health. Breeding 
and shipping of Slc26a4+/+ and Slc26a4-/- mice from Emory University was 
funded by grant NIH-R01-DK52935 to SW. Breeding of the mice at KSU 
and the work reported in this paper was supported by grant NIH-R01-
DC01098 to PW from the National Institutes on Deafness and Other 
Communication Disorders, National Institutes of Health. The Confocal 
Core and the Molecular Biology Core at KSU were funded by NIH-P20-
RR017686 from the National Institute for Research Resources, National 
Institutes of Health.
References
1. Pendred V: Deaf-mutism and goitre.  Lancet 1896, 11:532.
2. Reardon W, OMahoney CF, Trembath R, Jan H, Phelps PD:
Enlarged vestibular aqueduct: a radiological marker of pen-
dred syndrome, and mutation of the PDS gene.  QJM 2000,
93:99-104.
3. Fraser GR: Association of congenital deafness with goitre
(Pendred's syndrome). A study of 207 families.  Ann Hum Genet
1965, 28:201-249.
4. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F,
Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED: Pendred
syndrome is caused by mutations in a putative sulphate
transporter gene (PDS).  Nat Genet 1997, 17:411-422.
5. Blons H, Feldmann D, Duval V, Messaz O, Denoyelle F, Loundon N,
Sergout-Allaoui A, Houang M, Duriez F, Lacombe D, Delobel B,
Leman J, Catros H, Journel H, Drouin-Garraud V, Obstoy MF,
Toutain A, Oden S, Toublanc JE, Couderc R, Petit C, Garabedian EN,
Marlin S: Screening of SLC26A4 (PDS) gene in Pendred's syn-
drome: a large spectrum of mutations in France and pheno-
typic heterogeneity.  Clin Genet 2004, 66:333-340.
6. Bidart JM, Mian C, Lazar V, Russo D, Filetti S, Caillou B, Schlumberger
M: Expression of pendrin and the Pendred syndrome (PDS)
gene in human thyroid tissues.  J Clin Endocrinol Metab 2000,
85:2028-2033.
7. Royaux IE, Suzuki K, Mori A, Katoh R, Everett LA, Kohn LD, Green
ED: Pendrin, the protein encoded by the Pendred syndrome
gene (PDS), is an apical porter of iodide in the thyroid and is
regulated by thyroglobulin in FRTL-5 cells.  Endocrinology 2000,
141:839-845.
8. Scott DA, Karniski LP: Human pendrin expressed in Xenopus
laevis oocytes mediates chloride/formate exchange.  Am J
Physiol Cell Physiol 2000, 278:C207-C211.
9. Scott DA, Wang R, Kreman TM, Sheffield VC, Karniski LP: The Pen-
dred syndrome gene encodes a chloride-iodide transport
protein.  Nat Genet 1999, 21:440-443.
10. Chambard JM, Ashmore JF: Sugar transport by mammalian
members of the SLC26 superfamily of anion-bicarbonate
exchangers.  J Physiol 2003, 550:667-677.
11. Everett LA, Morsli H, Wu DK, Green ED: Expression pattern of
the mouse ortholog of the Pendred's syndrome gene (Pds)
suggests a key role for pendrin in the inner ear.  Proc Natl Acad
Sci USA 1999, 96:9727-9732.
12. Lacroix L, Mian C, Caillou B, Talbot M, Filetti S, Schlumberger M,
Bidart JM: Na(+)/I(-) symporter and Pendred syndrome gene
and protein expressions in human extra-thyroidal tissues.
Eur J Endocrinol 2001, 144:297-302.
13. Rillema JA, Hill MA: Prolactin regulation of the pendrin-iodide
transporter in the mammary gland.  Am J Physiol Endocrinol
Metab 2003, 284:E25-E28.
14. Royaux IE, Wall SM, Karniski LP, Everett LA, Suzuki K, Knepper MA,
Green ED: Pendrin, encoded by the Pendred syndrome gene,
resides in the apical region of renal intercalated cells and
mediates bicarbonate secretion.  Proc Natl Acad Sci USA 2001,
98:4221-4226.
15. Royaux IE, Belyantseva IA, Wu T, Kachar B, Everett LA, Marcus DC,
Green ED: Localization and functional studies of pendrin in
the mouse inner ear provide insight about the etiology of
deafness in pendred syndrome.  J Assoc Res Otolaryngol 2003,
4:394-404.
16. Suzuki K, Royaux IE, Everett LA, Mori-Aoki A, Suzuki S, Nakamura K,
Sakai T, Katoh R, Toda S, Green ED, Kohn LD: Expression of PDS/
Pds, the Pendred syndrome gene, in endometrium.  J Clin
Endocrinol Metab 2002, 87:938.
17. Wangemann P, Itza EM, Albrecht B, Wu T, Jabba SV, Maganti RJ, Lee
JH, Everett LA, Wall SM, Royaux IE, Green ED, Marcus DC: Loss of
KCNJ10 protein expression abolishes endocochlear poten-
tial and causes deafness in Pendred syndrome mouse model.
BMC Med 2004, 2:30.
18. Wall SM, Hassell KA, Royaux IE, Green ED, Chang JY, Shipley GL,
Verlander JW: Localization of pendrin in mouse kidney.  Am J
Physiol Renal Physiol 2003, 284:F229-F241.
19. Kim YH, Verlander JW, Matthews SW, Kurtz I, Shin W, Weiner ID,
Everett LA, Green ED, Nielsen S, Wall SM: Intercalated cell H+/
OH- transporter expression is reduced in Slc26a4 null mice.
Am J Physiol Renal Physiol 2005, 289:F1262-F1272.
20. Everett LA, Belyantseva IA, Noben-Trauth K, Cantos R, Chen A,
Thakkar SI, Hoogstraten-Miller SL, Kachar B, Wu DK, Green ED:
Targeted disruption of mouse Pds provides insight about the
inner-ear defects encountered in Pendred syndrome.  Hum
Mol Genet 2001, 10:153-161.
21. Ramakers C, Ruijter JM, Deprez RH, Moorman AF: Assumption-
free analysis of quantitative real-time polymerase chain
reaction (PCR) data.  Neurosci Lett 2003, 339:62-66.
22. Vetter DE, Mann JR, Wangemann P, Liu Z, McLaughlin KJ, Lesage F,
Marcus DC, Lazdunski M, Heinemann SF, Barhanin J: Inner ear
defects induced by null mutation of isk gene.  Neuron 1996,
17:1251-1264.
23. Wangemann P, Liu J, Marcus DC: Ion transport mechanisms
responsible for K+ secretion and the transepithelial voltage
across marginal cells of stria vascularis in vitro.  Hear Res 1995,
84:19-29.
24. El Amraoui A, Cohen-Salmon M, Petit C, Simmler MC: Spatiotem-
poral expression of otogelin in the developing and adult
mouse inner ear.  Hear Res 2001, 158:151-159.
25. Fujiwara N, Kobayashi K: Macrophages in inflammation.  Curr
Drug Targets Inflamm Allergy 2005, 4:281-286.
26. Solanes N, Rigol M, Ramirez J, Segales J, Roque M, Marimon JM, Perez-
Villa F, Roig E, Sanz G, Heras M: Histological basis of the porcine
femoral artery for vascular research.  Anat Histol Embryol 2005,
34:105-111.
27. Goldsby R, Kindt T, Osborne B: Immunology 4th edition. New York:
W.H. Freeman & Company; 2000. 
28. Henderson RB, Hobbs JA, Mathies M, Hogg N: Rapid recruitment
of inflammatory monocytes is independent of neutrophil
migration.  Blood 2003, 102:328-335.
29. Hirose K, Discolo CM, Keasler JR, Ransohoff R: Mononuclear
phagocytes migrate into the murine cochlea after acoustic
trauma.  J Comp Neurol 2005, 489:180-194.
30. Hashimoto S, Billings P, Harris JP, Firestein GS, Keithley EM: Innate
immunity contributes to cochlear adaptive immune
responses.  Audiol Neurootol 2005, 10:35-43.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1741-7015/4/37/prepubPage 15 of 15
(page number not for citation purposes)
